Archiwum hase³
squamous cell lung cancer | molecular profile | antimetastatic marker | lymph nodes metastasis | histamine release test | gating | aeroallergens | visceral total inversion | bilobectomy | combined pulmonary fibrosis and emphysema {CPFE} | pulmonary hypertension | secondary erythrocytosis | erythrocytosis | basal crackles | hypocapnia | ground glass changes | Ca-blocker | chronic respiratory failure | honey—combing | anaphylactic reactions | triple therapy | indacaterol | hyperaminoacidemia | palmar hereditary erythema | carbohydrate load | large neutral amino acid {LNAA} | carbohydrate consumption | hyperinsulinemia | peripheral glucose uptake (PGU) | hepatic glucose production (HGP) | house dust mites | cardiovascular complications | Epworth score | primary lung cancer | multibacterial colonization | multi-drug-resistant strains | lincosamides | streptogramins B | nicotine dependence | smoking-related diseases | motivation to quit test | pack years | vascular calcification | cardiovascular mortality | airway remodeling | bronchial hyper-responsiveness | basement membrane thickness | bronchial challenge with methacholin | fiberoptic bronchoscopy | reticular basement membrane | light microscope | bloody parapneumonic effusion | decortication | spontaneous hemothorax | parapneumonic effusion | mediastinal window | Langerhans cell sarcoma | bronchoesophageal fistula | Langerhans cell histiocytosis | malignant histiocytosis X | Birbeck granule | rough endoplasmic reticulum {RER} | coronal plane | multivariate analysis | stabilized fibrin degradation | risk of recurrence | multidrug-resistant tuberculosis {MDR-TB} | extensively drug resistant tuberculosis | induced sputum | chronic inflammatory airway diseases | general practitioner | pulmonologist | leprosy | colliquative tuberculosis focus | colliquative tuberculosis | nucleic acid amplification | oligomycobacterial material | submandibular area | submandibular lymphatic nodes | tubercular granulation | giant Lanhgans like cells | intercalation | extradural anaesthesia | nongenomic action | genomic action | gluco-corticoid receptor | dose-effect dependencydependency | lung microangiopathy | metabolic disorder | impaired insulin secretion | alveolar-capillary barrier | alveolocapillary barrier | alveolo-capillary barrier | lung diffusing capacity for carbon monoxide | hypersensitivity reactions | aspirin-induced asthma | aspirin intolerance | exposure to passive smoking | lacrymation | peripheral blood cells | antimycobacterial antibodies | shadowing | ophthalmological examination | neurofibromatosis type 1 | von Recklinghausen\'s disease | nongenomic effects of glucocorticoids | arachidonic acid cascade | arachidonic acid metabolism | endocannabinoid synthesis | carbonyl | hydrocortisone | hip adductor | pubic ligament | expander | chow | diffuse infantile familial sclerosis | visceral adiposity | pituitary adiposity | suckling | multiorgan symptoms of disease | constitutive genetic profiles | skin triceps fold thickness | alopecia in women | toxic alopecia | diffuse | disseminated alopecia | lanugo hair | stellate hair | beneficial | outpatients specialist care | outpatients clinics visits | exertional dyspnoea | outpatients care | nontuberculous mycobacteria | mycolic acid | high pressure liquid chromatography | early detection | program of early detection | screening program | low-dose spiral computed tomography | lobectomy | wedge resection | tuberculoma | preliminary results | mediastinal lymphadenectomy | sputum production | wheezing | complications of venous thrombosis | chest ultrasound | compression ultrasound | convex head | echoic reflexions | signs of mobility | echoic pulmonary parenchyma | hypoechoic area | subpleural foci | pulmonary parenchymal infarct | contrast-enhanced computed tomography | segmental arteries | atypical microorganism infections | clinical course of asthma | chronic lung diseases | stable asthma | predictor of the lung’s remodeling | airways’ remodeling | psychological variables | chronic respiratory system diseases | obstructive diseases | limb edema | gestational oedema | splanchnic | overall assessment | bronchial tree obstruction | total exposure to cigarette smoke | spirometric abnormalities | St. George’s Respiratory Questionnaire | weight loss | predictive values | prognostic values | cancer markers | inoperable non-small-cell lung cancer | non-small-cell lung cancer | performance status | neuron specific enolase | neuronal enolase | chronic respiratory system diseases | effect size | granules | granules for oral solution | gastro-resistant granules | effervescent granules | prolonged release granules | medical history | underdiagnosis | detectability | screening spirometry | anti-asthmatic medication | inhalation glucocorticoids | oral glucocorticoids | parenteral glucocorticoids |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
